Cargando…

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19

Detalles Bibliográficos
Autores principales:	Hennekens, Charles H., Rane, Manas, Solano, Joshua, Alter, Scott, Johnson, Heather, Krishnaswamy, Shiv, Shih, Richard, Maki, Dennis, DeMets, David L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381625/ https://www.ncbi.nlm.nih.gov/pubmed/34437834 http://dx.doi.org/10.1016/j.amjmed.2021.07.035

Ejemplares similares

Ivermectin in COVID-19: The Case for a Moratorium on Prescriptions
por: Molnar, Andreea, et al.
Publicado: (2022)

Genomic surveillance to combat COVID-19: challenges and opportunities
por: Robishaw, Janet D, et al.
Publicado: (2021)

Updates for Health Providers on Monoclonal Antibodies for COVID-19: Less Promising Adjunct and Never an Alternative to Vaccinations
por: Berges, Maja, et al.
Publicado: (2022)

Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions
por: Shih, Richard D., et al.
Publicado: (2020)

The menacing assaults on science, FDA, CDC, and health of the US public
por: Alter, Scott M., et al.
Publicado: (2020)

Evolution of Knowledge in the Treatment of Long-Standing Atrial Fibrillation in a UK Tennis Champion
por: Krishnaswamy, Shiv, et al.
Publicado: (2021)

Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies
por: Solano, Joshua J., et al.
Publicado: (2020)

Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
por: Caceres, Jennifer, et al.
Publicado: (2022)

Health Care Workers Need COVID-19 Vaccination: Clinical, Public Health, and Ethical Considerations
por: Maki, Dennis G., et al.
Publicado: (2021)

Newest Guidance and Evidence for Health Care Providers: COVID-19 and Other Vaccines
por: Rubenstein, Alexandra, et al.
Publicado: (2023)

Controversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases
por: Solano, Joshua J, et al.
Publicado: (2022)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Racial Inequalities in Mortality from Coronavirus: The Tip of the Iceberg
por: Levine, Robert S., et al.
Publicado: (2020)

Data monitoring committees: history and their future
por: DeMets, David L
Publicado: (2013)

Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age
por: Kim, Kyungmann, et al.
Publicado: (2021)

Prehospital Ketamine Administration for Excited Delirium with Illicit Substance Co-Ingestion and Subsequent Intubation in the Emergency Department
por: Solano, Joshua J., et al.
Publicado: (2021)

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19
por: Sandercock, Peter A. G., et al.
Publicado: (2022)

The Emerging Pandemic of Coronavirus and the Urgent Need for Public Health Leadership
por: Hennekens, Charles H., et al.
Publicado: (2020)

Corrigendum to “Health Care Workers Need COVID-19 Vaccination: Clinical, Public Health and Ethical Considerations” The American Journal of Medicine Vol. 134:12 p1437–1439
por: Maki, Dennis G., et al.
Publicado: (2022)

Does hydroxychloroquine reduce mortality for COVID-19?
por: GALLUS, Silvano, et al.
Publicado: (2020)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
por: Horby, Peter W., et al.
Publicado: (2020)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Guidelines for the prevention of surgical site infection: an update from NICE
por: Leaper, David, et al.
Publicado: (2019)

Has the door closed on hydroxychloroquine for SARS-COV-2?
por: Paul, Mical
Publicado: (2021)

Data monitoring in clinical trials: a case studies approach
por: DeMets, David, et al.
Publicado: (2006)

Achieving effective informed oversight by DMCs in COVID clinical trials
por: DeMets, David L., et al.
Publicado: (2020)

Update on hydroxychloroquine use in pregnancy
por: Nori, Wassan, et al.
Publicado: (2023)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Hydroxychloroquine in Dermatology and Beyond: Recent Update
por: Sardana, Kabir, et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome
por: Okour, Malek, et al.
Publicado: (2020)

Commentary: Preventing endophthalmitis after cataract surgery: An update
por: Agarwal, Aniruddha
Publicado: (2022)

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
por: Yang, Fred, et al.
Publicado: (2015)

Monitoring clinical trials in infectious diseases
por: DeMets, David L, et al.
Publicado: (2021)

Risk of using hydroxychloroquine as a treatment of COVID-19
por: Alanagreh, Lo’ai, et al.
Publicado: (2020)

Fundamentals of Clinical Trials
por: Friedman, Lawrence M, et al.
Publicado: (2010)

Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
por: Lekpa, Fernando Kemta, et al.
Publicado: (2021)

Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application
por: Grant, William B., et al.
Publicado: (2021)

Hydroxychloroquine and COVID-19: a Rheumatologist’s Take on the Lessons Learned
por: Udupa, Akrithi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7366uuqs4es2o839c91vieed12